期刊
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
卷 114, 期 11, 页码 1352-1362出版社
WILEY
DOI: 10.1111/j.1471-0528.2007.01525.x
关键词
cost-utility analysis; hysterectomy; uterine artery embolisation
资金
- National Institute for Health Research [03/60/01] Funding Source: researchfish
- Department of Health [03/60/01] Funding Source: Medline
Objectives To evaluate the relative cost-effectiveness of uterine artery embolisation (UAE) and hysterectomy in women with symptomatic uterine fibroids from the perspective of the UK NHS. Design Cost-utility analysis. Setting Eighteen UK NHS hospital trusts. Population or sample Women who underwent UAE (n = 649; average follow up of 8.6 years) or hysterectomy (n = 459; average follow up of 4.6 years) for the treatments of symptomatic fibroids. Methods A probabilistic decision model was carried out based on data from a large comparative cohort and the literature. The two interventions were evaluated over the time horizon from the initial procedure to menopause. Extensive sensitivity analysis was carried out to test model assumptions and parameter uncertainties. Main outcome and measures Costs of procedures and complications and quality of life expressed as quality-adjusted life years (QALYs). Results Overall, UAE was associated with lower mean cost (2536 pound versus 3282) pound and a small reduction in quality of life (8.203 versus 8.241 QALYs) when compared with hysterectomy. However, when the quality of life associated with the conservation of the uterus was incorporated in the model, UAE was shown to be the dominant strategy-lower costs and greater QALYs. Conclusions UAE is a less expensive option to the health service compared with hysterectomy, even when the costs of repeat procedures and associated complications are factored in. The quality of life implications in the short term are also predicted to favour UAE; however, this advantage may be eroded over time as women undergo additional procedures to deal with recurrent fibroids. Given the hysterectomy is the current standard treatment for symptomatic fibroids, offering women UAE as an alternative treatment for fibroids is likely to be highly cost-effective for those women who prefer uterus-conserving treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据